Breathing sevoflurane to help prevent ARDS in ICU patients
Part of Lungs & breathing clinical trials.
This Phase 3 trial tests whether inhaled sevoflurane (a breathing anesthetic) can help prevent ARDS, a serious lung injury, in high-risk ICU patients who need sedation. It aims to reduce the chance of developing ARDS by using this medication during the early period on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in a participating ICU and have at least one known ARDS risk factor
- You are on an invasive breathing machine (endotracheal ventilation)
- You are expected to need sedation for at least 4 hours
- You are covered by French social security (Sécurité Sociale)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more tailored way to set the amount of air delivered by a ventilator in people with severe ARDS. The goal is to see if personalized breathing settings can improve breathing and heart-related monitoring while patients are in intensive care.
This trial is comparing a new type of inhaled sedative (volatile sedation) to usual IV sedatives for people with ARDS who are on a ventilator in the ICU. It aims to see if it can help patients breathe better and recover more quickly.
This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.
This trial tests a new way to give sedation through a breathing mask (isoflurane gas) to people with severe head injuries. It aims to see if this method is safe and may help when IV sedatives alone are not enough.
This Phase 2 study tests whether a specific inhaled sedative (sevoflurane) is safe and helpful for people with septic shock who need ICU sedation and a breathing machine. It may improve how patients tolerate intensive care treatment, but eligibility is limited to a short time window after septic shock begins.
This Phase 3 trial tests a sedation approach using inhaled (“volatile”) anesthesia gases for children who need a ventilator. It aims to improve comfort and brain-related outcomes while they stay on the breathing machine for at least a day.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.